Pretty Cure Sub Indo
Nelson Suggs
Arabian Wind Pretty Cure! (アラビアンウィンドプリキュア, Arabian'uindo Purikyua!?) is a Pretty Cure fanseries that formerly belonged to by Minashima Akari, then StarcatcherDreams, but now belongs to Amai Minami. The theme motifs are jewels, fashion, and treasures.
Business Lorna Benson Aug 11, 2015 Minnesota Board of Animal Health staff tested chickens in a backyard flock for avian influenza in April 2015. While initial tests in chickens are encouraging, the bird flu vaccine has plenty of downside. Courtesy Minnesota Board of Animal Health Minnesota turkey farmers are clamoring to vaccinate their flocks this fall against avian influenza. But while initial tests in chickens are encouraging, experts say the vaccine has plenty of downside. Minnesota has lost more than 9 million turkeys and chickens to avian flu and the requirement to kill surviving birds to stop the disease from spreading. By the time the virus retreated in early June, the flocks of 108 Minnesota poultry farms had been wiped out. So there's not much debate among the state's turkey farmers about whether a vaccine should be used if the deadly virus returns. "In Minnesota we're pretty much unanimous that this is something we would use, if we have it," said Steve Olson, executive director of the Minnesota Turkey Growers Association. (Continue . . . )
But that said, you know, it's a very different environment, particularly when there's a political overlay. And this is a, you know, COVID is a very political story, the way that journalists approach that is very different to how you would go when you're talking to a patient, for example. So yeah, it was pretty confronting for someone that's not really used to the spotlight and public speaking is not my, is not my forte, but I hope that, you know, I sort of brought enough technical knowledge to it and explained it as best I could. There was some I think there was some odd times I remember trying to explain how a PCR works, I think it was in the context of, you know, why do we get false positive PCRs or something like that. And I've got about halfway through and then I realised all the journalists were sort of looking at their phones, and they'd all tuned out. So I'm not entirely sure if that was the most successful explanation, but hopefully, other ones were a bit better than that.
Yeah, look, it's it is difficult to know and a key unknown is sort of what is the driver of the new variants, and for new variants, firstly, are they you know, are they more severe, and how much did they evade the current vaccines. And so a big question is about whether we need variant vaccines and whether they work. They're actually some early indications, at least for Omicron, that a variant vaccine actually may not be much better than just giving the same dose of the existing vaccine. It's monkey experiments. It's all pretty early stage at the moment. But that's sort of a concept that's familiar to immunologist from flu, that sometimes when you give another vaccine, you're just, you know, boosting the existing cells and the existing antibodies rather than creating new types of antibodies. So that just goes to say that it is going to be fairly complicated going forwards. I think there probably is and needs to be a little bit of thinking about what it is that we're trying to do. And really, we're not trying to stop transmission. In that the aim is to stop people getting sick. And stopping transmission can be one way of doing that. But vaccinating people themselves, obviously, it's another way of that. And treatments are another method of that. And now that in a lot of countries, most people have probably been exposed to, to COVID, or to SARS2 at some level, perhaps we might need to step back and say, well, actually, who are we trying to give protection to now with the tools that we have, and what are the best ways to do that? I think, in general, vaccination is a it's cheap, it's one off, or at least less frequent than much less expensive than treatment, and prevention is generally better than cure, but where most people have got infection, we just need to think a little bit about, you know, who is it that still needs to be vaccinated. And in terms of, you know, are we going to have an annual vaccination, they're going to be flu type vaccines with multivirulent strains, we don't really know at this stage and WHO has set up a committee and I think, Raina MacIntyre and Kanta Subbarao are on on that committee, to really look at that question about, you know, do we need a flu type vaccine and obviously, the vaccine manufacturers are also well down the track in terms of developing those sorts of vaccines. I don't think they're technically difficult to make, but, you know, what is the strategy I think is important. And then how do we keep an eye on new variants. We're, you know, we're coming off the end of an Omicron outbreak, but, you know, we're up to that letter in the Greek alphabet. So you know, there are going to be more and anything that is going to spread must have an edge on whatever we've had, so that probably does mean it's going to be, going to evade immune system responses to some extent.
Wong, Barclays: There are a number of SOEs that are US dollar-denominated businesses and, as a result, they need funding in dollars. These are big companies and their financing needs are pretty large. But the process for them getting approval for their offshore borrowing takes a long time because they need to get signatures from six different ministers before they can tap the offshore market. This significantly reduces the ability of state-owned corporations to tap the market when an opportunity arises. They cannot hope to tap the market at the perfect moment, and this is something that should be revised by the government.
LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads) on and off LinkedIn. Learn more in our Cookie Policy.
Biden had only positive things to say about the Abraham Accords, and in indeed, if we see a Saudi breakthrough that would happen in the context of those accords. Democrats, Republicans can all agree that this was a positive move for the United States in the region. So too, that is true of this breakthrough, the Camp David principles with the most important US ally in Asia, Japan, and South Korea. Another very important ally of the United States, probably the second most important, certainly when you look at the troops that the Americans have positioned there. The level of regular engagement of certainly of the exercises that occur, the level of economic, of military aid and technology transfer that occurs, all of that is pretty significant. Here you have a relationship that really should have been much better between Japan and South Korea, and hasn't been for a long time, improved in part because the South Korea-China relationship got so much worse when the South Koreans decided they needed their THAAD missile defense system from the United States to defend them against North Korea.
That's still the case in many other parts of the world. We talk about it today in America and that means we now have a 95% cure rate because women -- for women who find it at the very early stages of the disease. But in many places, there's still a shame associated with it, a fear associated with it, a sense that it's a death sentence or that it's a private family matter and it's not something you can talk about.
UNDER SECRETARY HUGHES: Exactly, there -- well, there's a -- you know, there's a mix. I mean, obviously, because of my long association with President Bush, I'm able to meet with a lot of leaders and I think that's important because they're pretty open and honest with me. I can listen to their concerns and I can bring those back and relay them to Secretary Rice and to the President.
aa06259810